The antiparkinsonian drugs budipine and biperiden are use-dependent (uncompetitive) NMDA receptor antagonists

MLA

Rolf Jackisch, et al. “The Antiparkinsonian Drugs Budipine and Biperiden Are Use-Dependent (Uncompetitive) NMDA Receptor Antagonists.” European Journal of Pharmacology, vol. 264, no. 2, Oct. 1994. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....13500684a43f5c53c7ec2650db1b2f42&authtype=sso&custid=ns315887.

APA

Rolf Jackisch, Georg Hertting, Thomas J. Feuerstein, Willi Sauermann, & Alexander Kruchen. (1994). The antiparkinsonian drugs budipine and biperiden are use-dependent (uncompetitive) NMDA receptor antagonists. European Journal of Pharmacology, 264(2).

Chicago

Rolf Jackisch, Georg Hertting, Thomas J. Feuerstein, Willi Sauermann, and Alexander Kruchen. 1994. “The Antiparkinsonian Drugs Budipine and Biperiden Are Use-Dependent (Uncompetitive) NMDA Receptor Antagonists.” European Journal of Pharmacology 264 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....13500684a43f5c53c7ec2650db1b2f42&authtype=sso&custid=ns315887.